· Volume surge · RGC
Regencell Bioscience Holdings Ltd (RGC) loses 53.4% over four weeks
The healthcare stock’s selloff has deepened with turnover above normal and technical readings still pointing to pressure.
Regencell Bioscience Holdings Ltd (RGC) closed the latest week at $12.01, down -36.2% for the one-week period. The weekly price path over 52 weeks shows the move as part of a broader drawdown rather than a one-session swing.
Confirmation remains weak. The trend signal is inactive, Market Dynamics shows pressure at -1.46, and Relative Strength is deeply negative at -52.1, leaving the rebound case unsupported by the current technical tape.